Showing results (51-60 of 132) with videos related to

Sort By:
Pageof 14
Annals of Internal Medicine|February 1, 2003
Screening and surveillance for Barrett esophagus in high-risk groups: a cost-utility analysisJohn M Inadomi, Richard Sampliner, Jesper Lagergren, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 30, 2009
New model for end stage liver disease improves prognostic capability after transjugular intrahepatic portosystemic shuntJennifer Guy, Ma Somsouk, Stephen Shiboski, et al.
Frontiers in Public Health|April 25, 2024
Screening for social determinants of health among populations at risk for MASLD: a scoping reviewRebecca G Kim, April Ballantyne, Molly B Conroy, et al.
Gastroenterology|March 11, 2009
A cost-utility analysis of ablative therapy for Barrett's esophagusJohn M Inadomi, Ma Somsouk, Ryan D Madanick, et al.
Journal of the American College of Surgeons|March 30, 2011
Cost-effective treatment of patients with symptomatic cholelithiasis and possible common bile duct stonesLisa M Brown, Stanley J Rogers, John P Cello, et al.
JOP : Journal of the Pancreas|July 9, 2011
Inoperable pancreatic cancer patients who have prolonged survival exhibit an increased risk of cholangitisJames L Buxbaum, Scott W Biggins, Karen C Bagatelos, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|January 22, 2015
Gastric cancer in asian american populations: a neglected health disparityVictoria M Taylor, Linda K Ko, Joo Ha Hwang, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|October 4, 2014
The Impact of Uncertainty in Barrett's Esophagus Progression Rates on Hypothetical Screening and Treatment DecisionsSonja Kroep, Iris Lansdorp-Vogelaar, Alex van der Steen, et al.
JAMA Network Open|April 12, 2021
Model-Based Estimation of Colorectal Cancer Screening and Outcomes During the COVID-19 PandemicRachel B Issaka, Preston Taylor, Anand Baxi, et al.
Cancer|July 13, 2012
Preferences for outcomes associated with decisions to undergo or forgo genetic testing for Lynch syndromeMiriam Kuppermann, Grace Wang, Shirley Wong, et al.
Pageof 14